Citations : GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disorder

Dated: Nov 01, 2021

Publication Name: AAN PUBLICATIONS

To analyze (1) the effect of immunoglobulin G (IgG) from patients with anti–myelin oligodendrocyte glycoprotein antibody (MOG-Ab)–associated disorder on the blood-brain barrier (BBB) endothelial cells and (2) the positivity of glucose-regulated protein 78 (GRP78) antibodies in MOG-Ab–associated disorders.

Read More

Contributors: Fumitaka Shimizu, Ryo Ogawa, Yoichi Mizukami, Kenji Watanabe, Kanako Hara, Chihiro Kadono, Toshiyuki Takahashi, View ORCID ProfileTatsuro Misu, Yukio Takeshita, Yasuteru Sano, Miwako Fujisawa, Toshihiko Maeda, View ORCID ProfileIchiro Nakashima, Kazuo Fujihara, Takashi Kanda

Compare /

New DispenCell™ Single-Cell Dispenser technology isolates single cell lines 3x faster and at lower cost

Automated high-content screening solution with the BioAssemblyBot’s 6-axis robotic arm for optimized 3D tissue and organoid workflows

Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce

Search

TECHNICAL SUPPORT

INTRODUCING OUR NEW CUSTOMERCARE PORTAL

MOLECULAR DEVICES EXPANDS GLOBAL R&D HUB IN AUSTRIA

Search

Citations : GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disorder

MICROPLATE READERS

CELLULAR IMAGING

CLONE SCREENING

FLIPR SYSTEM

AXON PATCH-CLAMP

LAB AUTOMATION

GXP COMPLIANCE

GLOBAL HEADQUARTERS